Current Status of Financing and Reimbursement of Herceptin® (Trastuzumab) for Adjuvant and Advanced Therapy of Breast Cancer in Germany.

Volker Jacobs* (First author)

*Corresponding author for this work

    Research output: Contribution to journalOriginal Article (Journal)peer-review

    Original languageEnglish
    Pages (from-to)86-94
    JournalBreast care (Basel, Switzerland)
    Volume1
    Issue number2
    Publication statusPublished - 2006

    Cite this